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ABSTRACT 
 This study was conducted to compare the concentration of 
plasma enzymes in chronic renal failure pre dialysis (group A) and post 
dialysis (group B), and evaluate the concentration of these enzymes between 
pre and post dialysis.  
 The study was performed in 25 samples of Sudanese patients 
(chronic renal failure) and compared  with 15 samples as the control groups.  
Plasma samples were analyzed using spectrophotometer methods, plasma 
concentration of these enzymes showed increased in chronic renal failure pre 
and post dialysis. The mean values of lactate dehydrogenase pre dialysis is 
259IU/L, post dialysis is 276IU/L, the mean of creatine kinase pre dialysis is 
252IU/L, and post dialysis is 241 IU/L but the mean of amylase pre and post 
dialysis is the same 144 IU/L.  
This study showed that there is no difference of concentration of 
amylase enzyme, but the difference concentration of CK and LDH between 
pre and post dialysis during chronic renal failure depend on normal range of 
this enzyme in control groups.        
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 1 
INTRODUCTION 
 
The serum enzymes of patients with end-stage renal disease are 
abnormal. This is due in part to the absence of renal excretion and to the 
frequent comorbid conditions. Since the diagnosis of many disease is based 
upon the detection of these enzymes, the accurate clinical assessment of the 
patient with (ESRD) is concerning the serum conditions of different 
enzymes in various diseases. (Soundararajan and Golper, 2006).  
Serum levels of several commonly measured enzymes are abnormal in 
patients with end stage renal disease (ESRD). Beside serum total LDH 
activity in the ESRD group was midly but significantly higher than that 
found in the normal group.Single passage of blood through the 
extracorporeal apparatus led to a rise in total LDH, a pattern consistent with 
release from the platelets. A steady increase was noted in total LDH arterial 
blood during hemo dialysis. This was thought to be due to ultrafiltration – 
include hemo concentration. (Vaziri, et al.2006) 
Twenty percent of pancreatic enzyme is excreted by the kidneys. 
Thus, patients with end stage renal diseases (ESRD) have elevated levels of 
serum pancreatic enzymes. Serum pancreatic enzymes (amylase) are often 
elevated within threefold normal in ESRD patients. (Fung, et al., 2002). 
We determined serum levels of total amylase in a group of 
asymptomatic patients with end-stage renal disease (ESRD) before and after 
hemo dialysis. Pre dialysis serum total amylase activity in the asymptomatic 
ESRD patient was increased greater then the found in the normal group, and 
remained unchanged after hemo dialysis. (Chang, et al., 1988).  
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The objectives of the study:  
1. To measure the levels of LDH, CK and α  amylase pre and post hemo 
dialysis in chronic renal failure.                
2. To see the variations of the concentrations of LDH, CK and α  
amylase pre and post hemo dialysis in chronic renal failure.                
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Chapter One 
Literature review 
 
1.1. The kidney function 
The kidneys play  many functions, which can be as follows: 
The kidneys regulate the osmotic pressure of the body fluids. Since 
the cell volume is affected by extra cellar fluids(ECF) osmeolality, 
maintenance of a constant plasma osmeolality favors stability of intra 
cellular fluid volume. 
The kidneys regulates the volume of the ECF by the excretion of 
sodium and water. 
Also it regulates the individual concentrations of numerous 
electrolytes in the ECF, including sodium, potassium, hydrogen, calcium, 
magnesium, chloride, sulfate and phosphate ions. 
The kidneys eliminate waste products of metabolism, such as urea (an 
end product of protein metabolism), uric acid (an end products of purine 
metabolism), and creatinine (an end product derivated from muscle creatine 
phosphate). Also eliminate foreign compounds from the body e.g. drugs 
such as penicillin. 
The kidneys have a number of special substances which have 
important biological function, these include rennin, a proteolytic enzyme 
important in blood pressure regulation, Erythropoietin, a hormone that 
stimulate production and release of red blood cells from bone marrow. 
kallikrein, an enzyme that leads to production of kinins, which are 
vasodilator .And also various of prostaglandins family. 
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       Kidneys have several special metabolic functions, which are                                                     
responsible for the conversion of vitamin D to it’s active form in the body, 
1,25- dihydroxy- vit D3 ( 1,25-dihydroxy-cholecalciferon ) . 
They can synthesize glucose from non- carbohydrate sources (e.g. amino 
acids) a process called gluconeogenesis. During a prolonged fast, glucose 
added to blood by the kidneys helps to maintain the blood sugar 
concentration. The kidneys are important site of degradation (hence, of 
inactivation) of several polypeptide hormones for example insulin, glucagon 
and parathyroid hormones. 
The major job of the kidneys is to maintain stability of the composition and 
volume of the body fluids. The kidneys accomplish this by working on the 
blood plasma. In a healthy person the kidneys maintain conditions in the 
ECF at an optimal level for functioning of the body cells. The kidneys clean 
the blood by extracting unneeded materials in the urine. By unneeded 
materials not only the waste products of metabolism, not also substances that 
are in excess in the body, (Selkurt, 1982). 
1.2. Renal physiology 
1.2.1. Glomerular filtration 
About 20 percent of the plasma passes through the glomerular membrane 
into Bowman’s capsule and forms the glomerular ultra filtrate. 
The force involved in filtration at the glomerulus are the same as those 
operating to transfer fluid across a capillary. The major force causing 
filtration is the substantial hydrostatic pressure of the blood in the 
glomerular capillaries. Because there are relatively few branches between 
the aorta and glomerular capillaries and because of the effects of the efferent 
arterioles, the glomerular capillary pressure, 50 to 60 mmHg (7 to 8 pka), is 
higher than in normal capillaries. 
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Opposing this is the oncotic pressure of the plasma proteins, which don’t 
pass through the filter and the hydrostatic pressure of the fluid in Bowman’s 
space. The relationship between these forces is expressed as  
        PUF = (PGC-Pt)-osmPGC 
Where PUF is the ultra filtration pressure, PGC and Pt refer to hydrostatic 
pressure in the glomerular capillaries and tubule, and Osm PGC to oncotic 
pressure in glomerular capillaries. However, unlike other capillaries, the 
fluid transport into Bowman’s space is so great that the concentration of the 
plasma proteins rises markedly. In addition, the presence of the efferent 
arteriole ensures that the fall in hydrostatic pressure is minimal along the 
glomerular capillary (Smith et al., 1988). 
1.2.2.1 Protein 
About 8g of protein per day into glomerular filtrate (about 4g of this is 
albumin) at a concentration of about 40mg/l. Most of this is reabsorbed by 
pinocytosis in the proximal tubules through a small amount is passed in the 
urine. Normal urine contains 40-120mg/24h of protein, about half of which 
is derived from the plasma and the remainder is derived from the tubules and 
lower urinary tract, (Baron et al., 1989).  
1.2.3. Tubular secretion 
Tubular secretary processes, by which substances  move from per 
tubular capillaries into the tubular lumen,i.e, in the direction opposite to 
tubular reabsorption, constitute a second  pathway into the tubules, the first 
being glomerular filtration. Of the large number of different substances 
which can be transported into the tubules by tubular secretion, only a few are 
normally found in the body. The most important begin in the urine enters the 
tubules by secretion rather than by filtration. Thus, renal regulation of the 
two important substances is accomplished primarily by the mechanisms 
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which control the rate of their tubular secretion. The kidney is also able to 
secrete a large number of foreign chemicals, thereby facilitating their 
secretion from the body; penicillin is example (Vander et al., 1985) 
1.2.5 Threshold 
The threshold of a given constituent of the plasma is that 
concentration in the plasma above which, assuming normal glomerular and 
tubular function, it is excreted in the urine. The threshold of glucose is about 
10mmol/l. As the plasma concentration of glucose is normally below this, 
glucose can be called a threshold substance. Tubular reabsorption of glucose 
remove from the glomerular filtrate practically all the glucose that is filtered 
through the glomeruli at plasma glucose levels below 10 mmol/l by a 
suitable active transport mechanism. The threshold level of urea is zero, i.e. 
urea is excreted in the urine how ever low its concentration in the plasma, 
and  urea can be called a non- threshold substance. The threshold of any 
substance may be altered by physiological changes in the renal plasma flow, 
the glomerular permeability, or the tubular reabsorpative capacity (Baron et 
al., 1989). 
1.3 Renal disorder 
Failure of renal function may occur rapidly, producing the syndrome 
of acute renal failure. This is potentially reversible sign, if the patient 
survives the acute illness, normal renal function can be regained. However, 
chronic renal failure develops insidiously, often over many years, and is 
irreversible, leading eventually to end stage renal failure. Patients with end 
stage renal failure require either long term replacement (dialysis) or 
successful renal transplant in order to survive. (Marshall, 1995). 
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1.3.1. glomerular disease 
Disorder or diseases that directly damage the renal glomeruli may, at 
least initially, exhibit normal tubular function, with time, however, disease 
progression involves the renal tubules, as well (Bishop,etal., 2005).  
1.3.1.1. Acute glomerulo nephritis  
Pathologic lesions in acute glomerulo nephritis primarily involve the 
glomerulus. Histological examination shows large, inflamed glomeruli with 
a decreased capillary lumen. Abnormal laboratory findings usually include 
rapid onset of hematuria and proteinuria (generally, usually albumin 
<3g/day). The rapid development of a decreased GFR, anemia, elevated 
blood urea nitrogen(BUN) and serum creatinine, oliguria, sodium and water 
retention (with consequent hypertension and some localized edema), and 
some time, congestive heart failure typically. Numerous hyaline and 
granular casts are generally seen on urine analysis. The actual red blood cell 
casts are regarded as highly suggestive of this syndrome. Acute glomerulo 
nephritis is often related to recent infection by group A-β-hemolytic 
streptococci. It is theorize that circulating immune complexes trigger a 
strong inflammatory response in the glomerular basement membrane. 
Resulting in direct injury to the glomerulus itself. Other possible causes 
include drug related exposure, acute kidney infections due to other bacteria 
(and possibly, viral) agent and short systemic immune complex disease, such 
as systemic lupus erythematosus (SLE) and sub-acute bacterial endocarditic 
(SBE). (Bioshop et al., 2005).  
1.3.1.2 Chronic glomerulo- nephritis  
Length glomerular inflammation may lead to glomerular scarring and 
the eventual loss of functioning nephrons. This process often goes un 
detected for lengthy period because minor decreases in renal function occur 
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at first and only slight proteinuria and hematouria are observed. Gradual 
development of uremia (or azotemia,excess nitrogen compounds in the 
blood ) may be the first sign of this process. (Bioshop et al., 2005).  
1.3.1.3 Nephrotic syndrome 
The nephritic syndrome has been classically defended as clinical 
entity characterized by massive proteinuria, edema, hypo albuminemia, 
hyper lipidemia and lipiduria. This syndrome, which can have many causes, 
is chacterized by increased glomerular membrane permeability that results in 
massive proteinuria and excretion of ketone bodies. Protein excretion rates 
are usually greater than 2 to3 g/day in the absence of a depressed GFR. 
Hemauria and oliguria may be as result of the massive loss of serum protein, 
primarily albumin, into urine, the plasma protein concentration is decreased, 
with a concentration reduction in plasma oncotic pressure. This results in 
fluid movement from the vascular to interstitial aspace with consequent 
edema formation. (koplan, et al., 2003)  
1.3.1.4 Tubular diseases 
Tubular defects occur to a certain extent in the progression of all renal 
disease as the GFR fallas. In some instant, however, this aspect to over all 
dysfunction became predominant. The result is decreased excretion, 
reabsorption of certain substances or reduced urinary concentrating 
capability. Clinically, the most important defect is renal tubular acidosis 
(RTA), the primary tubular disorder affecting acid-base balance. This 
disease can be classified in two types, depending on the nature of the tubular 
defect: 
1. Distal RTA, in which the renal tubules are un able to keep up the 
vital pH gradient between the blood and tubular fluid.  
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2. Proximal RTA, in which there is decreased bicarbonate 
reabsorption, resulting in hyper chloremia acidosis.  
In general, reduced reabsorption in the proximal tubule is manifested 
by findings of abnormally low serum values for phosphorus, uric acid and by 
glucose and amino acid in urine. In addition, there may be some proteinuria 
(usually <2g/day). Acute inflammation of the tubules and surrounding 
interstitial also may occur as a result of analgesic drug or radiation toxicity, 
and viral, fungal and bacterial infection. Characteristic clinical findings in 
these cases are decreased in GFR, urinary concentrating ability, and 
metabolic acid excretion, leukocyte casts in the urine, and in appropriate 
control of sodium balance (Bishop et al., 2005) 
1.3.1.5 Urinary tract infection and obstruction  
The site infection may be either in the kidneys (pyelonphritis) or in the 
urinary bladder (cystitis). In general, a microbiologic colony count of more 
than 105 colonies/ml is considered diagnostic for infection in either locale. 
Bacteriuria (as evidenced by positive nitrite dipstick findings for some 
organisms), hematuria and pyuria (leukocytes in the urine, as shown by 
positive leukocyte esterase dipstick) are all frequently encountered abnormal 
laboratory results in these cases. In particular, white blood cell (leukocyte) 
casts in the urine is considered diagnostic for pyelonephritis (Bishop et al., 
2005). 
Renal obstructions can cause disease in one of two ways. They may 
either gradually raise the intra tubular pressure until nephrons necrosis and 
chronic renal failure ensues, or they may predispose the urinary tract to 
infections. Obstruction may be located in the upper and lower urinary tract. 
Blockages in the upper tract are characterized by a constricting lesion below 
adulated collecting duct. Obstruction of the lower tract are evidenced by the 
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residual urine in the bladder after cessation of micturition (urination), 
symptoms include slowness of voiding, both initially and throughout 
urination. Causes of obstructions can include neoplasm’s (such as prostate-
bladder carcinoma or lymph node tumors constricting ureters), acquired 
diseases such as urethral strictures or renal calculi and congenital 
deformities of the lower urinary tract. The clinical symptoms of advancing 
obstructive diseases include decreased urinary concentrating capability, 
diminished metabolic acid excretion, decreased GFR, and reduced renal 
blood flow. Laboratory tests usefull in determining the nature of the blacked 
are urinalysis, urine culture, BUN, serum creatinine, CBC. Final diagnosis is 
usually made by radiologic imaging techniques. (Bishop et al., 2005) 
1.3.1.7 Vascular diseases  
Hypertension: Long standing and severe hypertension can result in 
progression renal damage and chronic renal in sufficiency (hypertensive 
nephro sclerosis). In contrast, hypertension can be caused by the sodium and 
water retention that occurs in chronic renal failure, acute glomerulo 
nephritis, and the nephritic syndrome(volume- dependent hypertension), or it 
can occur as result of increased rennin release from chronically damage 
kidneys (rennin-dependent hypertension.(Koplan et al.,2003).  
Arteriotar disease: Disease of small arteries of the kidneys (arteritis) may 
occur in association with generalized disease processes affecting the kidney, 
such as systemic lupus erythematosus, poly arteritis nodosa, and progressive 
systemic sclerosis (sclerodema). These diseases may result in the clinical 
and biochemical abnormalities seen in acute glomerulo nephritis, the 
nephritic syndrome, or chronic renal in sufficiency (Koplan et al., 2003).  
Renal vein thrombosis. Thrombosis of the renal veins results in massive 
proteinuria and the nephritic syndrome .hypertension, edema, hematuria and 
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impaired renal function may accompany the proteinuria. (Koplan et al., 
2003). 
1.4 Renal failure  
Renal failure ,in which the end products of metabolism accumulate in 
excess in the body fluids, merges with the last stage of renal in sufficiency, 
in which the concentration of the end products are maintained within normal 
limits.(Gray, 1974) 
1.4.1 Acute renal failure  
Acute renal failure (ARF) refers to as sudden and usually reversible 
loss of renal function, which develops over period of days or weeks. An 
increase in plasma creatinine concentration to greater than 200 micro mol/l 
is often used as the biochemical definition. Chinese data suggests that 
patients with acute renal failure who are treated right a way, have an 89.6%-
92.1% chance of recovering normal kidney function. There are many causes 
of acute kidney failure but a common cause which can be prevented, or 
treated in conjunction with dialysis, is acute renal failure due to acute 
nephritic syndrome (Ahmed, 2005). 
Al though acute renal failure is potentially life threatening and may require 
intensive treatment, it usually reverses within several weeks to a few month 
after un derlying causes has been treated. A few people will progress to 
chronic renal failure or end stage renal disease. Death is most common when 
the causes of the renal failure are related to surgery or trauma or when it 
occurs in people with co existing heart disease, lung disease or recent stroke. 
Old age, infection, loss of blood from the gastro intestinal tract, and 
progression of the kidney failure also increase the risk of death. (Medline 
plus medical encylo pedia acute kidney failure.htm, 2000). 
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1.4.2 Chronic renal failure  
Renal failure is a common problem world wide, it is now more 
frequent in Sudan. One of most important function of the kidney is the 
endocrine and metabolic function. This is done in association with para 
thyroid gland. Chronic renal failure (CRF) is defined as persisting and 
progressive deterioration of renal function leading to retention of waste 
products of metabolism (Osman, 2005). 
Chronic renal failure is complicated by hypertension, bleeding tendency due 
to defect on platelets function, severe anemia due to bone marrow 
suppression and erythropoietin deficiency, infection, hyper uricemia, hyper 
phosphatemia and hyper kalemia (Osman, 2005). 
The management of CRF is mainly directed towards the under lying cause, 
so as to delay the progression of renal damage, and the complications 
(Osman, 2005). 
While the blood urea level reflects the degree of renal failure, also 
dietary protein tissue breakdown, and the serum creatinine are amore 
accurate guide to renal function. Other nitrogen products whose blood levels 
are elevated include uric acid. Serum sodium is often normal but may be low 
due to decreased tubular capacity to conserve sodium.  The same applies to 
potassium, although in very advanced causes the blood level may become 
high once the GFR falls to very low levels, or in association with oliguria or 
severe acidosis. The acidosis is of metabolic type and is characterized by a 
lowering pH, Pco2 and bicarbonate. The serum phosphate rises due to the 
decreased in phosphate filtered and this is usually associated with a fall in 
serum calcium. (Macswween and Whaley, 1992).  
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1.4.3 Hemo-dialysis  
Hemo dialysis involves exchanges between a patient’s plasma and a 
dialyate bath through semi permeable membranes. Vascular a ccess is 
achieved either through a temporary large intra venous double lumen cather 
or repeated cannulation of permanent, surgically constructed, arterio venous 
fistula.Complications involve mechanical obstruction,infection,hemorrhage, 
`and homodynamic in stability during or after dialysis therapy. The objective 
of dialysis therapy is the removal of toxin, metabolic waste products, and 
excess volume from the vascular space. Through the processes of ultra 
filtration and diffusion, solutes and material pass from the vascular space to 
a dialysate solution by crossing semi permeable membrane.(Ahmed,2005).  
1.4.4 Peritoneal dialysis  
Peritoneal dialysis involves the sterile intrduction of dialysate fluid 
into the peritoneum through a surgically implanted cather. The dialysate 
fluid is then allowed to equilibrate with patient’s plasma for specific a mount 
of time by adjusting the dialysate material and the length of time, the 
consistency of materials plasma can be adjusted. The fluid is later with 
drowning under sterile condition. ALthough multiple modalities of 
peritoneal dialysis are available, the one most commonly used is continuous 
ambulatory peritoneal dialysis (CAPD). In this modelity, the dwell time 
daily. Because of its ease of use, avoidance of hemodynamic instability from 
rapid volume shifts and freedom from use of dialysis centre, CAPD is 
favored by younger patients, the elderly, and those with severe cardio 
vascular problem. Because CAPD is relatively stable, condition such as 
hypo tension, chest pain, and neurological deficits should not be attributed to 
the dialysis process (Ahmed, 2005).  
1.5. Lactate deyhdrogenase   
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(E.C 1.1.1.27, L. lactate: NAD oxido reductase, LDH, LD )  
Lactate dehydrogenase is ahydrogen transfer enzyme that catalyzes the 
oxidation of L. lactate to pyruvate with the mediation of NAD as hydrogen 
acceptor to the reaction is reversible and the equilibrium strongly favors the 
reverse reaction, namely, the reduction of pyruvate to lactate. (Tietz, 1987).  
 
L. lactate +NAD      LDH      pyruvate+ NADH+H  
 
The pH optimum for the lactate to pyruvate reaction is 8.8-9.8, and an 
optimal assay mixture at 30 °C. The optimal pH varies among the different 
iso- enzymes and dependent on the temperature as well as on substrate and 
buffer concentrations. The specificity of the enzyme extends from L. lactate 
to a variety of related alpha- hydroxyl acids and alpha –axo-acids, for 
example, catalytic oxidation of alpha –hydroxy butyrate to alpha –axo 
butyrate is referred to as alpha- hyroxy butyrate deyhrogenase (HBDH) 
activity. LDH does not act on D. lactate, and only NAD will serve as 
coenzyme. The enzyme has a MW of 134000 and is composed of four 
peptide chains (sub unit) of two type. M and H, which are determined by 
loci on human chromosomes 11 and 12, respectively (Tietz, 1987).  
Lactate dehrogenases are inhibited by reagents such as mercuric ions and p-
chlor mercuric benzoate that reacts with thiol group. The inhibition is 
reversed by the addition of thiol reagents such as cysteine or glutathione. 
Borate and oxalate inhibit by competing with lactate for the binding site on 
the enzyme, similarly, oxalate competes with pyruvate for its binding site. 
Both Pyruvate and lactate in excess inhibit enzyme activity, al though the 
effect of pyruvate is greater. For the H form than the M form, and substrate 
inhibition decreases with increase in pH. EDTA inhibits the enzyme, 
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perhaps by binding Zn, however, the postulated activator role for zinc ions 
fully established. (Tietz, 1987). 
The enzyme is widely distributed in the body, with high concentration 
in cells of cardiac and skeletal muscle, liver kidney, brain, and erythrocytes. 
Measurement of plasma total LD activity is therefore a non specific marker 
of cell damage.(Mayne,1994).  
1.5.2. Cause of raised plasma total LDH activity  
Art factual due to in vitro haemolysis or delayed separation of plasma 
from whole blood, marked increase (more than 5 times the upper reference 
limit in adults), circulating failure with shock and hypoxia, myocardial 
infraction and some haematologic disorders. In blood disease such as 
megaloblastic anaemia, acute leukemia and lymphomas, very high levels (up 
to 20 times the upper reference limit in adults) may be found. Smaller 
increase occur in other disorders of erythropoiesis such as thalassaemia, 
myelofibrosis and hemolytic anemia, renal infraction,or accasionally during 
rejection of a renal transplant, moderate increase, viral hepatitis, malignancy 
of any tissues, skeletal muscle disease, pulmonary embolism, and infectious 
mono nucleosis (Mayne, 1994).  
1.6. Creatine kinase (CK) 
Creatine phospho kinase, also known as CK, is a mitochondrial and 
cytoplasmic enzyme with tissue distribution. The mitochondrial iso form, 
found in skeletal and cardiac cells, catalyzes the transfer of phosphate from 
adenosine tri phosphate (ATP) to creatine to from creatine phosphate. 
Creatine phosphate serves as an energy reserve for periods of high energy 
needs such as during muscle contraction. Cytoplasmic CK catalyzes the 
reverse reaction of phosphate transfer from creatine phosphate to generate 
ATP, there by providing an immediate energy source. The cytoplamic from 
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of CK is a dimmer of two sub units, M and B, generating the three different 
iso enzyme combinations MM, MB and BB. All three forms have been 
found in the cytoplasm, associated with myofibril structure. (Lewandrowski, 
2002). 
1.6.1 CK in muscular metabolism  
The enzyme (CK) catalyzes the reversible transfer of phosphate 
residue in high energy bonding between ATP to creatine. It is classified as 
E.C on 2.7.3.2 in the enzyme catalogue. The reaction product, phospho 
creatine, represent essential energy store for contraction, relaxation, and 
transport of substances within the muscle cells. The primary energy source is 
ATP.For contraction the energy is released by myosine ATPase; for 
relaxation by calcium ATPase principally ATP is recharged from oxidative 
phosphoryation. In periods of increased demand ATP also can be re- 
charged from phospho creatine by CK. For emergency demand another 
pathway is available. The production of one molecule ATP via dis 
protionation of two molecules adenosine diphosphate (ADP) by the enzyme 
adenylate kinase. Further more, CK is also involved in the oxidative 
phospharlyation in mitochondria of muscle, heart and brain. The enzyme 
seems to be located on the outer mitochondrial membrane. Re synthesis of 
phospho creatine from ATP could be catalyzed by mitochondrial creatine 
kinase. It is obvious that CK is to be considered as a key enzyme of muscle 
metabolism. Most of its activity is concentrated within the muscular organs. 
The enzyme can be constituted up to 20% of soluble sarco plasmic protein in 
some type of muscle. (Muhee-Aldeen, 1997). 
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1.7. Alpha amylase (EC 3.2.1.1.)  
Human amylase or alpha amylase is one of few enzymes that cleaves 
substrates of larger molecular mass than its own. The enzyme hydrolyzes 
alpha-1,4glycosidic bonds in polymers of glucose such as starch, glycogen 
and dextrin. Amylase cleaves internal bonds in these poly- saccharides to 
produce maltose, maltotriose.. The enzyme can not hydrolyze maltose to 
glucose; however, it has been reported to split malto triose to glucose and 
maltose. The natural substrates, such as starch and glycogen, contain both 
amylo pectin and amylase. Human amylase can not hydrolyze the alpha- 1,6 
branch links of amylo pectin, there for even after extensive digestion, limit 
dextrin’s remain. Enzymatic digestion of amylase yields maltose and some 
larger dextrins. (Lott and Wolf, 1986).  
1.7.1. Structure of amylase  
Amylase has a molecular mass of about 55,000 Daltons; both salivary 
and pancreatic amylase are believed to exist as single peptide chains rather 
than as aggregates or combinations of sub units as in, for example LDH. 
Amylase is a metallo enzyme containing tightly bound calcium. Calcium 
appears to be necessary for the stability of the enzyme, and it endows 
amylase with abroad pH range of activity from pH 6.5 to 8.5. Maximal 
amylase activity is near pH 7.5.  Salivary amylase requires a minimum of 
one mole of calcium ions per mole of amylase protein for maximal activity. 
Chloride, although not required as a cofactor, greatly increases the enzyme 
activity. Other ions such as acetate and phosphate have lesser effect than 
chloride to activate amylase (Lott and Wolf, 1986).  
Serum amylase is released from the pancreas (p-form) and salivary gland (s- 
form). The serum amylase, may be elevated in pancreatitis, and variety of 
other conditions. Amylase can increase within few hours after the onset of 
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acute pancreatitis and typically returns to normal level within 3 to 4 days. 
The clinical specificity for the diagnosis of acute pancreatitis is rather low 
(4%); there- fore, the diagnostic value for an elevated amylase alone without 
regard to other clinical findings is limited. In chronic pancreatitis, the serum 
amylase is often normal (or even low) and is less useful than in acute 
pancreatitis because of a reduction in functional pancreatic tissue in 
advanced chronic pancreatitis (Lewandrowski, 2002).  
Because amylase is cleared by the kidney, in patients with renal 
failure the serum amylase level may be increased. Another condition called 
macro amaylasemia is observed in a fraction of apparently healthy 
individuals. In this condition, the amylase is bound to immunoglobulin, and 
the complex is too large to be cleared by kidney. This condition gives rise to 
a form of hyperamylasemia, which does not reflect renal disease or other 
conditions known to elevate amylase levels in serum (Lewandrowski, 2002).  
1.7.2. Amylase clearance  
Comparied of renal clearance of amylase with clearance of creatinine, 
the amylase creatinine /clearance ratio (ACCR), has been useful in 
diagnosis. The ACCR is readily calculated from amylase activity and 
creatinine concentration determined from the same urine and from a single 
serum specimen obtained at the time of urine collection. The calculation is 
sumplifired to:   
ACCR (%) = urine amylase (U/L) X serum creatinine (mg/dl) 
Serum amylase (U/L) X urine creatinine (mg/dl) X 100  
Because volume and time are identical, they cancel out. Therefore, 
timed urine collection is unnecessary and random or short (2-4h) collections 
are adequate. The reference range for ACCR is 2-5%, but it is affected by 
the type of amylase assay used. Thus, it is imperative to establish a reference 
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range for the assay method currently in use. In acute pancreatitis tubular 
absorption of amylase and other proteins is reduced (probably due to 
competition from other low molecular weight proteins) and ACCR is 
increased; values >8% are not uncommon. Caution be exercised in 
interpreting increased ACCR values because elevations have been observed 
also in burns, keto acidosis, renal insufficiency, myeloma, light chain 
proteinuria, and march hemoglabinuria, and following extra corporeal 
circulation, large intra venous doses of corticosteroids, duodenal perforation, 
and extra peritoneal surgical procedures. In a macroamylasemia ACCR is 
usually < 2% (Tietz, 1987).  
1.7.3. Macroamylasemia ( hyper amylasemia )  
The serum amylase concentration reflects the balance between the 
rates of amylase entry and removal from the blood. Hyperamylasemia can 
result either from an increased rate of entry of amylase into the circulation 
and /or decreased metabolic clearance of this enzyme. The pancreas and 
salivary glands have amylase concentration that is several orders of 
magnitude greater than that of any other normal tissue, and these two organs 
probably acount for almost all these serum amylase activity in normal 
persons. A variety of techniques now available to distinguish pancreas from 
salivary type iso amylase. Pancreatic hyperamylasemia results from an insult 
to the pancreas, ranging from trivial (cannlation of the pancreatic duct) to 
severe pancreatitis. In addition, loss of bowel integrity (infraction or 
perforation) cause pancreatic hyperamylasemia due to absorption of amylase 
from intestinal lumen. Hyperamylasemia due to salivary type iso amylase is 
observed in conditions involving the salivary gland. In addition, this type of 
hyperamylasemia occurs in conditions in which there is no clinical evidence 
of salivary gland disease, such as chronic alcoholism, postoperative states     
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( particularly post coronary by pass), lactic acidosis, anorexia nervosa  or 
bulimia, and malignant neoplasms that secrete amylase. Hyperamylasemia 
can also result from decreased metabolic clearance of amylase due to renal 
failure or macroamylasemia (condition in which an abnormally high 
molecular weight amylase is present in the serum). Patients with abdominal 
pain and a markedly elevated serum amylase (more than three times the 
upper limit of normal) usually have acute pancreatitis, and additional serum 
enzyme testing is not helpful. Patients with smaller elevations of serum 
amylase often have conditions other than pancreatitis, and measurement of a 
serum enzyme more specific for the pancreas (pancreatitic iso amylase 
lipase or trypsin) is frequently of diagnostic value in such patient (Bigelow 
et al., 1988).                       
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CHAPTER TWO 
Materials and methods 
2.1. Subjects 
Subjects included in this study were 25 chronic renal failure patients 
(pre and post dialysis). Group A (pre dialysis), group B (post dialysis), with 
age range between (17-76) years from patients attending in Ibn sina hospital 
from (Kidney Dialysis Centre) and other 15 healthy Sudanese people (group 
C) from people works in Ibn sina hospital were taken as a control group. 
Samples were collected and analyzed during  the period from 2/2/2006 to 
2/3/2006. 
2.2. Materials  
2.2.1. Blood samples 
Afasting venous blood samples from each patient (5ml) and control 
was obtained using disposable syringes containing anticoagulant. Then 
centrifuged at 5000 r.p.m for 10 minutes to separate plasma from blood 
cells. Plasma is kept into a tightly covered containers at -20C till it is used 
later for estimation of plasma lactate dehydrogenase, creatine kinase and 
amylase. 
2.3 Chemicals  
All chemicals that used in this study were commercial kits obtained 
from Linear Chemical,  
a- lactate dehydrogenase kit.   
b- Creatine kinase kit. 
c- Amylase kit. 
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2.4. Methods 
2.4.1 Estimation of plasma lactate dehydrogenase (IU/L) 
Plasma total lactate dehydrogenase concentration was estimated using 
photometric method. 
A- Reagent composition 
 Final concentration  Composition  
  Reagent 1 
0.60 mmol/L  Pyruvate  
50 mmol/L Phosphate  
 Reagent 2 
0.18 mml/L NADH 
 Goods buffer, pH 9.6 
 B- principl                            
LDHPyruvate + NADH + H       lactate +NAD←→  
Reaction is buffered at physiological pH to favor equilibrium to lactate.  
Abbreviation:- 
LDH = lactate dehydrogenase  
NAD = nicotinamide adenine dinucleotide 
NADH = reduced NAD 
 
C- procedure 
Pipetted into test tubes              37 oC 
Reagent 1                              1000 micro liter 
Sample                                 10 micro liter 
 
 
Mixed. Incubate approximately (1-5 minutes). Then added  
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Reagent 2                               250 micro liter 
Mixed and read initial absorbance against air after 1minute and start a timer. 
Readed absorbance again after exactly 1, 2 and 3 minutes. 
Determine       A/ min. 
D. calculations (light path 1cm) 
LDH (IU/L) =      A/ min X factor  
Factor at 340 nm at 37 oC is 20000. 
2.4.2. Estimation of plasma creatine kinase (IU/L) 
Plasma creatine concentration was measured using photometric 
method. 
A- Reagent composition  
Final concentration  Composition 
 Reagent 1and reagent 2 
100 mmol/L Imidazole pH 6.7 
30 mmol/L Creatine phosphate  
20 mmol/L Glucose  
20 mmol/L N-acetyl cysteine  
10mmol/L Magnesium acetate 
2 mmol/L EDTA-Na2 
2 mmol/L ADP 
5 mmol/L AMP 
10 micro mol/L Diadenosine penta phosphate  
>  1.5 KU/L Glucose-6-phosphate-DH 
>  2.5 KU/L Hexo- kinase 
2mmol/L NAD p 
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B- Principl  
Creatine + ATP    CK       Creatine phosphate + ADP      
6-PG + NAD PH +H     G-6-P-DH        G-6-P + NAD P  
The coupled enzyme system is completely "down hill", i.e. all reactions 
proceed in a favorable direction. The pH optimum for the system is 6.7 
Abbreviations: 
ADP= adenosine-5-diphosphate  
AMP= adenosine-5- monophosphate 
ATP= adenosine-5- triphosphate  
CK= creatine kinase  
HK= hexo- kinase 
G-6-P= glucose-6-phosphate 
G-6-P-DH= glucose-6-phosphate dehydrogenase 
NAC= N-acetyl-L-cysteine 
NAD P= nicotinamide adenine dinucleatide phosphate 
NAD PH= reduced NAD P 
6-PG= 6-phospho gluconate  
C- Procedure 
sample blank Pipetted into test tubes  
50 micro liter _ Sample 
      _ 50 micro liter Distal water  
1000 micro liter   Reagent 1 
  Mixed. Incubate for 
approximately  
3 minutes. Then added  
250 micro liter   Reagent 2 
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  Mixed and read initial absorb after 2 minutes. At 37oC and start a timer. 
Readed absorbance again after exactly 1, 2 and 3 minutes at 37 oC. 
D- Calculations (light path 1cm)        
CK-NAC (IU/L) =      A/min X Factor  
Factor for 340 nm at 37 oC is 4127. 
2.4.3 Estimation of plasma amylase concentration (IU/L):- 
Amylase in plasma was measured using photometric method. 
A- Reagent composition 
Final concentration composition 
100 mmol/L MES Ph 6.0 
2.25 mmol/L CNP G3 
350 mmol/L Sodium chloride  
6 mmol/L Calcium acetate  
900 mmol/L Potassium thiocyanate  
0.95 gr/L Sodium azide  
 
B- Principl 
Amylase  hydrolyzes the 2-chloro-4- nitro phenyl- alpha- D- 
maltotrioside (CNPG3) to release 2-chloro-4-nitro phenol (CNP) and from 
2-chloro-4- nitro phenyl –alpha- maltoside (CNPG2), malto triose (G3) y 
glucose (G) according to the following reaction:                                         
                     
10 CNPG3      Amylase    9 CNP + 1CNPG2 + G3 + G                         
The rate of 2-chloro-4-nitro phenol formation, measured photo 
metrically, is proportional to the catalytic concentration of alpha- amylase 
present in the sample. 
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C- Procedure 
      1- Assay conditions: 
                 Wavelength                           405 nm 
                  Cuvette                                1 cm light path  
                 Constant temperature             37 oC  
    2- Adjust the instrument to zero with distilled water. 
    3- Pipetted into a cuvette 
    Reagent (ml) = 1.0 and addition  
   Sample (ml) = .002 (plasma amylase) in one test tube 
   4- Mixed- incubate for 2 minute. 
    5- Readed initial absorbance (A) of the sample, start the stop watch and 
readed absorbance at 1 minute intervals thereafter for 3 minutes.  
   6- Calculate the difference between absorbance and the average 
absorbance difference per minute (    A/min) 
 D- Calculations 
plasma AA/min X3954 = U/L AMs.   
2.4 Statistical analysis:  
The data obtained were analyzed by computer soft ware SPSS 10 program.  
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Chapter Three 
Results 
The range of age is from 17 to 76 years for all groups and the mean of 
age as follows 47 years (group A and group B) and the mean of group C is 
30 years. The distribution of sex among the study group is as follows group 
A and group B (pre and post dialysis) contain 18 males and 7 females and 
group C (control group) all of these groups are males (15 males).  
 Table 1: The mean of plasma level of total lactate dehydrogenase, 
creatine kinase and α- amylase concentration for patients and control 
groups 
 
a: = insignificant difference  
a , b, c: =  significant difference 
3.1 Plasma total lactate dehydrogenase: 
Table (1), fig. (1) show that group A (predialysis) has the high level of 
plasma total lactate dehydrogenase concentration in the study group, 
followed by group B (post dialysis) while group C has a normal value. 
Parameters  
GroupC 
(mean±SD) 
n = 15 
Group A 
(mean±SD) 
n = 25  
Group B 
(mean±SD) 
n = 25 
Lactate 
dehydrogenase 
192.2±2.2424a 259.56± 6.19b 276.96± 6.17c 
Creatine kinase 
 
72.40± 14.82a 252.00± 19.14a 241.88± 18.19a 
α- amylase 
 
62.93± 10.39a 144.56± 13.17a 144.00± 12.89a 
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There is significance difference between group A (predialysis) and group C, 
also there is significant difference between group B (post dialysis) and group 
C (healthy persons). 
3.2 Plasma total creatine kinase: 
Table (1), Fig. (2) show that group A (predialysis) has the highest level of 
plasma total creatine kinase concentration in the study group, followed by 
group B (post dialysis) while group C has a normal value. 
There is statistically insignificant difference between group A (predialysis) 
and group C, also there is insignificant difference between group B (post 
dialysis) and group C (healthy persons). 
3.3 Plasma α- amylase: 
Table (1), fig. (3) show that group A (predialysis) has the highest level of 
plasma total α- amylase concentration in the study group, followed by group 
B (post dialysis) while group C has a normal value. 
There is statistically insignificant difference between group A (predialysis) 
and group C, also there is insignificant difference between group B (post 
dialysis) and group C (healthy persons). 
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Fig (2) the levels of total creatine kinase
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Fig (3) the levels of total amylase
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Chapter Four 
Discussion 
 
            Renal failure, in which the end products of metabolism accumulate in 
excess in body fluids, merges with the last stage of renal insufficiency, in 
which the concentration of the end products are maintained within normal 
limit (Gray,1974).  
         Renal failure is a common problem world wide; it is now more 
frequent in Sudan. One of the most important function of the kidney is the 
endocrine and metabolic function. CRF is defending as persisting and 
progressive deterioration of renal function leading to retention of waste 
products of metabolism (Osman, 2005).  
4.1. Plasma total lactate dehydrogenase   
              Table (1) and fig. (1) showed that group A (LDH pre dialysis) has 
high level in plasma in CRF compared to group C (healthy people). This 
supported the idea that the study findings suggested lactate dehydrogenase is 
one of the urinary enzyme i.e. LDH cleared by the kidney, in the renal 
failure this enzyme will be retented in the plasma. When the causes of the 
Renal failure are related   to surgery or trauma or when it occurs in people 
with co existing heart disease.(Medline plus medical encyclopedia acute 
kidney failure. htm, (2000).  
Table (1) and fig. (1) showed that group B (LDH post dialysis) has 
high level in plasma in CRF compared to group C (healthy people). This 
supported the idea has been suggested LDH own high molecular weight 134 
KDa and composed of four polypeptide and then will not pass through 
glomerular membrane filtration, and also charge selective permeability.  
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4.2. Plasma total  creatine kinase    
               Table (1) and fig. (2) showed that group A (CK pre dialysis) has 
high level in plasma in CRF compared to group C (healthy people). This 
supported the idea, it is has been suggested CK one of urinary enzyme i.e. to 
be cleared in the kidney. When renal damage doesn’t be cleared and then 
will be accumulated in the blood (high level). When the causes of the renal 
failure are related to surgery or trauma or when it occurs in people with co 
existing heart disease (Medline plus medical encylo pedia acute kidney 
failure (htm, 2000).  
              In chronic renal failure patients, non specific elevations, of CK-MB 
can cause false positive results at rates of 20% to 30% in the absence of 
myocardial injury. This elevation has been attributed to increase rexpression 
of fetal CK-MB in myopathic   skeletal muscles in renal patients. Injured 
skeletal muscle, undergoing regeneration, may produce increase in the 
amount of CK-MB to reach the proportion found in myocardium. Total 
lactate dehydrogenase may elevate for similar reasons (Alam and Lieb, 
2002).  
            Table (1) and fig. (2) showed that BB (CK post dialysis) has high 
level in plasma in CRF compare to healthy persons. This supported the idea, 
the study findings suggested CK has a high molecular weight 41 KDa and its 
not pass through the glomerular membrane filtration and the charge of 
glomerular membrane permeability.  
           That CK is elevated in both hemo dialysis and ambulatory peritoneal 
dialysis patients particularly in men and blacks, that CK levels are probably 
related to muscle mass, and that CK declines with advancing age. Although 
blacks have higher CK values as a whole. (Singland, et al., 1988).  
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4.3. Plasma total alpha- amylase  
    Table (1) and fig. (3) Showed that group A (amylase pre dialysis) 
has high level in plasma in CRF compare to healthy persons. This supported 
idea, the amylase is cleared by the kidney, in patient with renal failure serum 
amylase may be increased. Another condition called macroamylasemia is 
observed in a fraction of apparently healthy individuals. In this condition, 
the amylase is bound to immunoglobulin, and the complex is too large to be 
cleared by kidney. This condition gives rise to a form of hyperamylasemia, 
which doses not reflect renal disease or other condition known to elevate 
amylase levels in serum. (Lewandrowski, 2002).  
              Table (1) and fig. (3) showed that group B (amylase post 
dialysis),has high level in CRF. This supported idea, hyperamylasemia can 
also result from decreased metabolic clearance of amylase due to renal 
failure or maroamylasemia (condition in which an abnormally high 
molecular weight amylase is present in the serum) (Bigelow et al., 1988). 
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Conclusions 
               No difference of levels concentration of amylase enzyme but I have 
found different levels of (LDH, CK) in pre and post hemo dialysis in CRF. 
In pre dialysis all these enzymes will be cleared by kidney, and then post 
dialysis will contain abnormally high molecular weight present in plasma.    
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Appendices 
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Questionnaire 
 
Name :………………………….  Serial No……………… 
Age…………………………….. Sex …………………… 
Type of Dialysis ………………… Triple ……………… 
Chronic renal Failure duration …………………………… 
Chronic renal Failure Medication…………………………. 
Diabetes Mellitus …………………………………………. 
Hypertension    …………………………………………. 
Heart diseases…………………………………………… 
Acute pancreatitis ……………………………………….. 
 
Investigation:   Pre   Post 
- LDH      …….  …….. 
- CK     …….  …….. 
- Amylase     …….  …….. 
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